Barring a market meltdown in the second half of December, it looks like 2024 will be a very successful year for the Mickleboro ASX share portfolio. As things stand, I am poised to record a return of over 40% for the 12 months. How did I get here? My exposure to high-quality companies in the tech, retail, and healthcare sectors helped my portfolio outperform this year.
The star of the show was undoubtedly my overweight position in ( ). At the time of writing, the location technology company's shares are up 200% year to date. The now departed also gave me significant funds to reallocate elsewhere after being taken over by Renesas this year.
I didn't stick around to see the takeover complete. Instead, I locked in the gains in April and reinvested them back into the tech sector through ( ) and ( ). Both of these ASX tech stocks have rocketed in value since then, compounding the funds even further.
I like to buy high-quality companies when an opportunity presents itself. This proved successful with ( ) and ( ) last year. ResMed's shares were down heavily because of weight loss wonder drug concerns.
They have returned approximately 50% this year. Whereas doom and gloom in the retail sector dragged youth fashion retailer Universal Store to very inviting levels. Its shares are up approximately 85% in 2024.
Also contributing to the good performance were ASX share portfolio holdings such as ( ) and ( ), ( ), and the ( ). I also took advantage of a sharp pullback in the ( ) share price..
